|Bid||0.00 x 0|
|Ask||12.04 x 3000|
|Day's Range||10.48 - 11.31|
|52 Week Range||9.85 - 20.72|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Today I will take a look at Spero Therapeutics Inc’s (NASDAQ:SPRO) most recent earnings update (30 June 2017) and compare these latest figures against its performance over the past fewRead More...
A group of four companies priced their initial public offerings late Wednesday and are gearing up to start trading later Thursday. Utility Evoqua Water Technologies Corp. priced its IPO at $18 a share, ...
Ringing today's closing bells are Ignacio Cueto, chairman of the board at LATAM Airlines Group S.A., at the NYSE and Ankit Mahadevia, MD, Spero Therapeutics president and CEO, at the Nasdaq.